Unitaid
is to roll out a generic version of the latest AIDS drug that can improve and
prolong the lives of tens of thousands of people who suffer severe side effects
and resistance to other treatments in Nigeria.
Unitaid, a global health initiative, said a
generic of Dolutegravir (DTG), first approved in the U.S. in 2013, is being
given to 20,000 patients in Kenya before being rolled out in Nigeria and Uganda
later in the year.
DTG is the drug of choice for people with HIV
in high-income countries who have never taken antiretroviral therapy before and
for those who have developed resistance to other treatment.
Kenya is the first African country to start
using the DTG.
No comments:
Post a Comment